Anna Rosa Garbuglia

3.7k total citations · 1 hit paper
120 papers, 2.1k citations indexed

About

Anna Rosa Garbuglia is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Anna Rosa Garbuglia has authored 120 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 57 papers in Hepatology and 49 papers in Infectious Diseases. Recurrent topics in Anna Rosa Garbuglia's work include Hepatitis C virus research (44 papers), Hepatitis B Virus Studies (43 papers) and HIV Research and Treatment (19 papers). Anna Rosa Garbuglia is often cited by papers focused on Hepatitis C virus research (44 papers), Hepatitis B Virus Studies (43 papers) and HIV Research and Treatment (19 papers). Anna Rosa Garbuglia collaborates with scholars based in Italy, United States and Japan. Anna Rosa Garbuglia's co-authors include Maria Rosaria Capobianchi, Daniele Lapa, A. Benedetto, Antonino Di, Paola Del Porto, Enrico Girardi, Roberto Salvi, Francesco Montella, Simonetta Pulciani and Emanuela Giombini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Anna Rosa Garbuglia

117 papers receiving 2.1k citations

Hit Papers

Epidemiological, clinical and virological characteristics... 2022 2026 2023 2024 2022 100 200 300

Peers

Anna Rosa Garbuglia
Anna Rosa Garbuglia
Citations per year, relative to Anna Rosa Garbuglia Anna Rosa Garbuglia (= 1×) peers Christopher J. Burrell

Countries citing papers authored by Anna Rosa Garbuglia

Since Specialization
Citations

This map shows the geographic impact of Anna Rosa Garbuglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rosa Garbuglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rosa Garbuglia more than expected).

Fields of papers citing papers by Anna Rosa Garbuglia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rosa Garbuglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rosa Garbuglia. The network helps show where Anna Rosa Garbuglia may publish in the future.

Co-authorship network of co-authors of Anna Rosa Garbuglia

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rosa Garbuglia. A scholar is included among the top collaborators of Anna Rosa Garbuglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rosa Garbuglia. Anna Rosa Garbuglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salichos, Leonidas, Chiara Taibi, Gianpiero D’Offizi, et al.. (2025). Exploring Predictive Factors for Bulevirtide Treatment Response in Hepatitis Delta-Positive Patients. Biomedicines. 13(2). 280–280. 1 indexed citations
2.
Romeo, Maria Anele, et al.. (2024). Heat Treatment as a Safe-Handling Procedure for Rift Valley Fever Virus. Pathogens. 13(12). 1089–1089. 2 indexed citations
3.
Garbuglia, Anna Rosa, et al.. (2024). Update on Hepatitis C Vaccine: Results and Challenges. Viruses. 16(8). 1337–1337. 5 indexed citations
4.
Meschi, Silvia, et al.. (2024). Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg. Viruses. 16(3). 412–412. 3 indexed citations
5.
Lapa, Daniele, et al.. (2024). Rift Valley Fever Virus: An Overview of the Current Status of Diagnostics. Biomedicines. 12(3). 540–540. 11 indexed citations
6.
Balestrieri, Maria Luisa, et al.. (2024). Remission of HPV-Related Diseases by Antivirals for Herpesvirus: Clinical Cases and a Literature Review. Viruses. 16(5). 756–756. 2 indexed citations
7.
Bordi, Licia, Giuseppe Sberna, Eleonora Lalle, et al.. (2023). Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant. International Journal of Molecular Sciences. 24(5). 4847–4847. 4 indexed citations
8.
Balestrieri, Maria Luisa, et al.. (2023). Conventional therapy for genital herpesvirus and remission of HPV-related lesions: a case series. Infectious Agents and Cancer. 18(1). 36–36. 2 indexed citations
9.
Matusali, Giulia, Fabrizio Carletti, Cesare Ernesto Maria Gruber, et al.. (2023). Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis. Diagnostics. 13(9). 1573–1573. 6 indexed citations
10.
Minosse, Claudia, Giulia Matusali, Silvia Meschi, et al.. (2023). Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients. Vaccines. 11(11). 1656–1656. 3 indexed citations
11.
Bettini, Aurora, Daniele Lapa, & Anna Rosa Garbuglia. (2023). Diagnostics of Ebola virus. Frontiers in Public Health. 11. 1123024–1123024. 15 indexed citations
12.
Berno, Giulia, Lavinia Fabeni, Giulia Matusali, et al.. (2022). SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods. Pathogens. 11(9). 1058–1058. 19 indexed citations
13.
Vergori, Alessandra, Alessandro Cozzi‐Lepri, Giulia Matusali, et al.. (2022). SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH. Viruses. 14(8). 1710–1710. 18 indexed citations
14.
Minosse, Claudia, Cesare Ernesto Maria Gruber, Martina Rueca, et al.. (2021). Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs. Viruses. 13(6). 1151–1151. 7 indexed citations
15.
Giuliani, Eugenia, Francesca Rollo, Maria Gabriella Donà, & Anna Rosa Garbuglia. (2021). Human Papillomavirus Oral Infection: Review of Methodological Aspects and Epidemiology. Pathogens. 10(11). 1411–1411. 12 indexed citations
16.
Bartolini, Barbara, Raffaella Lionetti, Emanuela Giombini, et al.. (2015). Dynamics of HCV genotype 4 resistance-associated variants during virologic escape with pIFN/RBV+daclatasvir: A case study using ultra deep pyrosequencing. Journal of Clinical Virology. 66. 38–43. 11 indexed citations
17.
Garbuglia, Anna Rosa, Marco Gentile, Franca Del Nonno, et al.. (2015). An anal cancer screening program for MSM in Italy: Prevalence of multiple HPV types and vaccine-targeted infections. Journal of Clinical Virology. 72. 49–54. 16 indexed citations
18.
Bordi, Licia, Claudia Caglioti, Anna Rosa Garbuglia, et al.. (2015). IFNL4 and IFNL3 Associated Polymorphisms Strongly Influence the Spontaneous IFN-Alpha Receptor-1 Expression in HCV-Infected Patients. PLoS ONE. 10(2). e0117397–e0117397. 10 indexed citations
19.
Lanini, Simone, Stefano Menzo, Vincenzo Puro, et al.. (2014). A Large Epidemic of Hepatitis B in Serbia: An Integrated Model for Outbreak Investigations in Healthcare Settings. Infection Control and Hospital Epidemiology. 35(6). 732–735. 2 indexed citations
20.
Garbuglia, Anna Rosa, et al.. (1993). Virus-free survival and down-regulation of CD4 in C8166 cells infected with human immunodeficiency virus type 1 at low density. Journal of General Virology. 74(12). 2595–2601. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026